TO THE QUESTION OF CHOOSING A NAME FOR A MEDICINAL PRODUCT

И. Ишинов; Л. Травушкина

Авторы

И. Ишинов ООО «Эрфис»
Л. Травушкина Magpharm lab

Ключевые слова:

товарный знак, интеллектуальная собственность, нейминг, торговое наименование, дженерика.

Аннотация

В настоящей работе представлен анализ особенностей нейминга в фармацевтической промышленности в Российской Федерации. В статье рассматривается роль статуса МНН при создании инновационных лекарственных препаратов, а также значение в формировании и развитии новых лекарственных брендов на российском и международном рынках таких средств идентификации, как товарный знак, торговое наименование. Обращается внимание на необходимость создания национальной системы экспертного отбора непатентованных наименований и законодательное закрепление правовой охраны МНН и ННН, а также осуществление жесткого контроля со стороны государства.

Биографии авторов

И. Ишинов , ООО «Эрфис»

патентный поверенный, директор

Л. Травушкина, Magpharm lab

патентный поверенный, канд. фарм. наук

Библиографические ссылки

Civil Code of the Russian Federation. Part 4) from 18.12.2006 N230-FZ (as amended on 07/03/2016) // Parliamentary newspaper. 12/21/2006. N 214, 215

State reform program "Pharma 2020". M .: October, 2009, 70 p.

Egorov VA, Abdulmanova EL History of pharmacy: a textbook for students of the pharmaceutical faculty. Samara: OOO "Etching", GOUVPO "SamGMU" 2nd edition, 2004

Radchenko N.A. Homogeneity and its impact on the fate of the trademark "Journal of the Intellectual Property Rights Court", No. 8, June 2015, from. 49-58

Zanina I.A., Razdorskaya I.M. The concept of "Brand" in the pharmaceutical market: the meaning and relationship with the main means of drug identification. VSU Bulletin, Series: Chemistry. Biology. Pharmacy. 2017. No. 4. S. 112-116.

Information letter dated November 5, 2008 No. 10/37 - 646/23 "On the classification of biologically active food additives in accordance with the International Classification of Goods and Services and on the establishment of their homogeneity with other goods and services for the purpose of registration of trademarks."

Loshakov L.A. System of international and national generic names of medicines. // Bulletin Roszdravnadzor. 2008, No. 6. S. 31-33.

Natradze, A.G. ... Chemical and pharmaceutical industry - medicine. - M .: Knowledge, 1985, 64 p.

National priority project "Health". M .: Prof, 2008, 327 p.

On international non-proprietary names materials from the site http://www.antibiotic.ru/cmac/pdf/9 2 121.pdf).

Pogrebnyak A.V. Molecular modeling and design of biologically active substances. Rostov-on-Don: Publishing house SKNTs VSh, 2003. - 229 p.

Ministry of Health and Social Development Russia, Roszdravnadzor MZiSR. Order of the Ministry of Health of Russia No. 429 dated June 29, 2016 "On approval of the Rules for the rational choice of names of drugs for medical use." Law No. 86-FZ dated June 22, 1998

Ministry of Health and Social Development Russia, Roszdravnadzor MZiSR. Rational choice of drug names: guidelines. Order No. 429n of June 29, 2016 of the Ministry of Health of Russia "On approval Rules for the rational choice of the names of medicinal products for medical use ”.

Salo V.M. On the history of the opening of the first pharmacy in the Russian state. Pharmacy No. 1, 2003;

Federal Law of June 22, 1998 "On Medicines" No. 86-FZ.

Chupandina E.E., Slivkin A.I., Safonova State and prospects for the development of pharmaceutical management in Russia // Pharmacy. - 2006. - No. 5. - S. 16-18.

Yavorsky D.Ya. Pharmaceutical trade mark: the problem of choice // Pharmacy. - 2007. - No. 8. - S. 22-24.

Event Reporting System (FDA, CDER, MedWatch program, Office of Post-Marketing Drug Risk Assessment, National Cooidonating Counsil for Safe Medication Practices) / Phillips J. [et al.]. - JAMA, 1998, 279,1200-5.

Peculiarities of naming in the pharmaceutical business. // Kazakhstan Pharmaceutical Bulletin, 2009 http://pharmnews.kz/news/osobennosti_nejminga_v_f armbiznese / 2009-07-15-2411)